In addition to functional approaches, a bioinformatics approach called Prediction of T Cell Epitopes for Cancer Therapy (ProTECT) has been recently developed to identify ALK neoepitopes from recurrent ALK R1275Q mutation [37]. Here, ALK is linked to cancer.